|
We are excited to announce that Circularity Healthcare, makers of D’OXYVA® is a Platinum Sponsor at the International and Biotherapy Conference 2015 and is launching across Asia at this event. (PRWEB) September 15, 2015 (Read article on PRWeb.com: http://www.prweb.com/releases/2015/09/prweb12955413.htm) The International Wound & Biotherapy Conference 2015 is an event organized by the Malaysian Society of Wound Care Professionals in Malaysia. The conference brings together in one platform the biggest names in the business, including internationally recognized authorities from forty countries in the field of wound care and biotherapy. It is an ideal setting for in-depth discussions with hundreds of experts on recent scientific advances and innovations to improve the management of complex and chronic wounds. Come and learn about some of the most advanced scientific discoveries from distinguished speakers on microcirculation, vascular surgery, endocrinology, and neurology. Circularity will be showcasing the latest breakthrough clinical evidence from a number of studies conducted pairing D’OXYVA® with the most advanced noninvasive diagnostics at the conference this October 16-18 in Sunway Pyramid Convention Centre, Kuala Lumpur, Malaysia. Circularity Healthcare CEO, Norbert Kiss has stated, "I'm glad our company is being represented at such a distinguished event and I personally want to thank the Malaysian Wound Care Society for organizing this event. Our company is extremely enthusiastic about utilizing this venue to launch our business in several countries across Asia." About Circularity Healthcare Circularity Healthcare, LLC, headquartered in the U.S. is an emerging world leader in proprietary circulatory health and non-invasive delivery technologies, committed to helping improve lives by developing, manufacturing, and marketing consumer health and wellness products. Circularity specializes in groundbreaking non-invasive technologies for highly portable medical gas-powered transdermal delivery systems and is pursuing regulatory approvals worldwide for device usage as treatment of disease states related to cardiovascular blood flow. About International Wound and Biotherapy Conference 2015 International Wound & Biotherapy Conference 2015 is an event organized by the Malaysian Society of Wound Care Professionals in Selangor, Malaysia that aims to bring together the biggest names and internationally recognized authorities from forty countries in the field of wound care and biotherapy in one single platform for in-depth discussion with hundreds of experts on recent scientific advances and innovations to improve the management of complex and chronic wounds. For More Information Please visit http://www.circularityhealthcare.com or http://www.doxyva.com and send your general inquiries via the Contact Us page, or for specific inquiries contact Circularity Public Relations at pr(at)circularityhealthcare(dot)com or by phone toll free at 1-855-5DOXYVA or at 1-626-817-6685 or 1-626-244-8090. Forward-Looking Information This press release may contain forward-looking information. This includes, or may be based upon, estimates, forecasts and statements as to management’s expectations with respect to, among other things, the quality of the products of Circularity Healthcare, LLC, its resources, progress in development, demand, and market outlook for non-invasive transdermal delivery medical devices. Forward-looking information is based on the opinions and estimates of management at the date the information is given and is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those initially projected. These factors include the inherent risks involved in the launch of a new medical device, innovation and market acceptance uncertainties, fluctuating components and other advanced material prices, new federal or state governmental regulations, the possibility of project cost overruns or unanticipated costs and expenses, uncertainties relating to the availability and costs of financing needed in the future and other factors. The forward-looking information contained herein is given as of the date hereof and Circularity Healthcare, LLC assumes no responsibility to update or revise such information to reflect new events or circumstances, except as required by law. Circularity Healthcare, LLC makes no representations or warranties as to the accuracy or completeness of this press release and shall have no liability for any representations (expressed or implied) for any statement made herein, or for any omission from this press release. |